It's All About/Charity/Sacramento/Researching Type 1 Diabetes
Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/42361 Sacramento city, capital of California, U.S., and seat (1850) of Sacramento county, in the north-central part of the state. It is situated in the Sacramento Valley (the northern portion of the vast Central Valley) along the Sacramento River at its confluence with the American River, about 90 miles (145 km) northeast of San Francisco and 45 miles (72 km) north of Stockton. The city site itself is flat, but the land gradually rises to the east on the approach to the foothills of the Sierra Nevada. The area experiences long, hot, dry summers and cool, damp winters with periodic foggy spells. Sacramento, one of the state’s oldest incorporated communities, lies at the heart of a four-county metropolitan area. Suburbs—concentrated largely to the north and east of the city—include Citrus Heights, Folsom, Carmichael, North Highlands, and Roseville. Maidu peoples were early inhabitants of the region. In the 1770s the valley was visited by Spanish explorer Pedro Fages, who named the river for the Christian religious sacraments. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Type 1 diabetes (T1D) kills the body’s beta cells that produce insulin which gives us the energy we need for everyday life. JDRF’s vision, the Beta Cell Restoration Program, will not only stop the autoimmune attack but also return the number of beta cells to a normal level. JDRF is developing vaccines that will re-train the immune system to eliminate autoimmunity and leave the beta cells alone. Type 1 diabetes (T1D) can occur in anyone—not just kids. If you or an adult you know has recently been diagnosed with T1D, check out the JDRF T1D Care Kit, a free resource containing information and tools to educate, support and inspire newly diagnosed adults. JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
The main points are –
nucleoside reverse transcriptase inhibitors,diabetes diagnosis,tolazamide,impaired glucose tolerance,Sac,insulin dependent,rapid insulin injection,LDL Cholesterol,SMBG,hypoglycemia,Roche Diabetes Care,symptoms of T1D,Basal Insulin,Action to Control Cardiovascular Risk in Diabetes Trial,UK Prospective Diabetes Study,insulin pumps,high blood glucose,prediabetes,diabetes self-management education,Clinicians,blindness,CRFD mortality,show your support,TypeOnesie,help,complications of diabetes,Beta Cell Regeneration,CFRD,JDRF family,basal rate,EsTiD,Rapid Insulin,Chapter Volunteer Outreach Chairs,contribution,diabetic mastopathy,JDRFCC,(DCCT),Artificial Pancreas,get involved,sugar breakdown,Stoke,Abstracts of JDRF Research,Research Summit,autoimmune therapies,adult-onset diabetes,Glucose,Insulin Nation,Blood Glucose,insufficient insulin production,GLP-1 agonists,Clinical Trials,Insulin Pump Therapy,T1D Care Kit,new treatment,very-long-acting insulin,DKA,heart attack,Insulin,preventive therapies,Cure,Severe.